Featured News
545NewsProviding Low-Cost Ransomware Protection to Small and Medium Businesses in Asia Pacific
SecureTasks and Comodo Security Solutions sign strategic partnership agreement BLOOMFIELD , USA /SINGAPORE – News Direct – 17 March 2022 – SecureTasks,...
- 639Wire Stories
NJ Biopharmaceuticals LLC and JEOL Ltd. Are Excited to Announce Their Collaboration to Bring Innovative Drug Discovery Platform Solutions Using JEOL’s 800 MHz NMR!
PRINCETON, N.J.–(BUSINESS WIRE)–$ADCS #ADCS–NJ Bio is procuring an 800 MHz NMR spectrometer with a cryogenic probe from JEOL. As part of this...
- 548Wire Stories
Fastly Named a Leader in IDC MarketScape for Worldwide Commercial CDN 2022 Vendor Assessment
Fastly’s large, software-defined network supporting 192 terabits per second (Tbps)1 of connected edge capacity recognized for speed, security, and reliability SAN FRANCISCO–(BUSINESS...
- 875Wire Stories
MapleStory Announces Double Trouble Superstars Update With the Addition of Yeti x Pink Bean World Character Creation
New Update Boasts New Content Including Joining Spring Singles’ or Couples’ Army Along With Significant Game Client Improvements, New Missions and Event...
- 608Wire Stories
Klaxoon Introduces Engage Edition, the New Generation of Its Workshop Platform
With major updates on Board Hybrid, Session, Memo, Question, up to the Network features, Engage Edition represents Klaxoon’s biggest technology improvement to...
- 525Wire Stories
Zynga and StarLark Celebrate Golf Rival’s Fourth Anniversary
World’s Second Largest Mobile Golf Game Celebrates Milestones While Inviting Players to Hit the Links in New Anniversary In-game Events SAN FRANCISCO–(BUSINESS...
- 572Wire Stories
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Biolexis has in-licensed AKS-452, a room temperature stable COVID-19 vaccine developed on Akston’s proprietary Fc fusion protein platform Biolexis will launch AKS-452...
- 550Wire Stories
Insurance Fraud Report 2022: Real Time Data, A Crucial Asset In Fraud Fighting
A 2022 study by FRISS reveals the importance of real time insights from real time data to secure end to end protection...
- 547Wire Stories
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries
Biolexis has in-licensed AKS-452, a room temperature stable COVID-19 vaccine developed on Akston’s proprietary Fc fusion protein platform Biolexis will launch AKS-452...
- 605Wire Stories
IperionX Presentation to Jefferies Aerospace and Defense Group
CHARLOTTE, N.C.–(BUSINESS WIRE)–$IPX #3Dprinting—IperionX Limited (“IperionX” or “Company”) (ASX: IPX) is pleased to provide a link to yesterday’s presentation to Jefferies Aerospace...
- 558Wire Stories
Insurance Fraud Report 2022: Real Time Data, A Crucial Asset In Fraud Fighting
A 2022 study by FRISS reveals the importance of real time insights from real time data to secure end to end protection...
